PortfoliosLab logo
SNN vs. BSX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SNN and BSX is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

SNN vs. BSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Smith & Nephew plc (SNN) and Boston Scientific Corporation (BSX). The values are adjusted to include any dividend payments, if applicable.

400.00%500.00%600.00%700.00%800.00%900.00%December2025FebruaryMarchAprilMay
540.61%
835.09%
SNN
BSX

Key characteristics

Sharpe Ratio

SNN:

0.58

BSX:

1.76

Sortino Ratio

SNN:

0.95

BSX:

2.27

Omega Ratio

SNN:

1.15

BSX:

1.36

Calmar Ratio

SNN:

0.35

BSX:

2.58

Martin Ratio

SNN:

1.34

BSX:

10.56

Ulcer Index

SNN:

12.40%

BSX:

3.79%

Daily Std Dev

SNN:

27.76%

BSX:

22.33%

Max Drawdown

SNN:

-55.20%

BSX:

-89.15%

Current Drawdown

SNN:

-36.71%

BSX:

-3.13%

Fundamentals

Market Cap

SNN:

$12.57B

BSX:

$154.22B

EPS

SNN:

$0.94

BSX:

$1.37

PE Ratio

SNN:

30.45

BSX:

76.09

PEG Ratio

SNN:

0.95

BSX:

2.58

PS Ratio

SNN:

2.16

BSX:

8.79

PB Ratio

SNN:

2.38

BSX:

6.99

Total Revenue (TTM)

SNN:

$5.81B

BSX:

$17.55B

Gross Profit (TTM)

SNN:

$4.05B

BSX:

$11.79B

EBITDA (TTM)

SNN:

$1.24B

BSX:

$4.09B

Returns By Period

In the year-to-date period, SNN achieves a 17.20% return, which is significantly higher than BSX's 15.16% return. Over the past 10 years, SNN has underperformed BSX with an annualized return of 0.08%, while BSX has yielded a comparatively higher 19.59% annualized return.


SNN

YTD

17.20%

1M

9.63%

6M

18.60%

1Y

16.07%

5Y*

-4.54%

10Y*

0.08%

BSX

YTD

15.16%

1M

6.29%

6M

16.56%

1Y

38.81%

5Y*

21.98%

10Y*

19.59%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SNN vs. BSX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SNN
The Risk-Adjusted Performance Rank of SNN is 6868
Overall Rank
The Sharpe Ratio Rank of SNN is 7373
Sharpe Ratio Rank
The Sortino Ratio Rank of SNN is 6464
Sortino Ratio Rank
The Omega Ratio Rank of SNN is 6868
Omega Ratio Rank
The Calmar Ratio Rank of SNN is 6868
Calmar Ratio Rank
The Martin Ratio Rank of SNN is 6868
Martin Ratio Rank

BSX
The Risk-Adjusted Performance Rank of BSX is 9393
Overall Rank
The Sharpe Ratio Rank of BSX is 9494
Sharpe Ratio Rank
The Sortino Ratio Rank of BSX is 8989
Sortino Ratio Rank
The Omega Ratio Rank of BSX is 9191
Omega Ratio Rank
The Calmar Ratio Rank of BSX is 9595
Calmar Ratio Rank
The Martin Ratio Rank of BSX is 9595
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SNN vs. BSX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Smith & Nephew plc (SNN) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current SNN Sharpe Ratio is 0.58, which is lower than the BSX Sharpe Ratio of 1.76. The chart below compares the historical Sharpe Ratios of SNN and BSX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00December2025FebruaryMarchAprilMay
0.58
1.76
SNN
BSX

Dividends

SNN vs. BSX - Dividend Comparison

SNN's dividend yield for the trailing twelve months is around 2.65%, while BSX has not paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
SNN
Smith & Nephew plc
2.65%3.05%2.75%2.79%2.17%1.78%1.51%1.96%1.76%2.08%1.71%1.52%
BSX
Boston Scientific Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

SNN vs. BSX - Drawdown Comparison

The maximum SNN drawdown since its inception was -55.20%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for SNN and BSX. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%December2025FebruaryMarchAprilMay
-36.71%
-3.13%
SNN
BSX

Volatility

SNN vs. BSX - Volatility Comparison

Smith & Nephew plc (SNN) and Boston Scientific Corporation (BSX) have volatilities of 7.23% and 7.46%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%16.00%December2025FebruaryMarchAprilMay
7.23%
7.46%
SNN
BSX

Financials

SNN vs. BSX - Financials Comparison

This section allows you to compare key financial metrics between Smith & Nephew plc and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


1.00B2.00B3.00B4.00B5.00B20212022202320242025
2.98B
4.66B
(SNN) Total Revenue
(BSX) Total Revenue
Values in USD except per share items

SNN vs. BSX - Profitability Comparison

The chart below illustrates the profitability comparison between Smith & Nephew plc and Boston Scientific Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%62.0%64.0%66.0%68.0%70.0%72.0%20212022202320242025
69.5%
68.8%
(SNN) Gross Margin
(BSX) Gross Margin
SNN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Smith & Nephew plc reported a gross profit of 2.07B and revenue of 2.98B. Therefore, the gross margin over that period was 69.5%.

BSX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported a gross profit of 3.21B and revenue of 4.66B. Therefore, the gross margin over that period was 68.8%.

SNN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Smith & Nephew plc reported an operating income of 329.00M and revenue of 2.98B, resulting in an operating margin of 11.0%.

BSX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported an operating income of 921.00M and revenue of 4.66B, resulting in an operating margin of 19.8%.

SNN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Smith & Nephew plc reported a net income of 198.00M and revenue of 2.98B, resulting in a net margin of 6.6%.

BSX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported a net income of 674.00M and revenue of 4.66B, resulting in a net margin of 14.5%.